Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited)

v3.22.1
Condensed Consolidated Statements of Changes in Stockholders' Deficit (Unaudited) - USD ($)
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance, amount at Dec. 31, 2020 $ (24,796,965) $ 21,971 $ 10,798,536 $ (35,655,163) $ 37,691
Beginning balance, shares at Dec. 31, 2020   21,970,638      
Net income (loss) 88,737     88,737  
Foreign currency translation loss (79,207)       (79,207)
Stock options exercised 10,999 $ 50 10,949    
Stock options exercised, share   50,000      
Share-based compensation 316,640 $ 55 316,585    
Share based compensation, share   55,000      
Ending balance, amount at Mar. 31, 2021 (24,459,796) $ 22,076 11,126,070 (35,566,426) (41,516)
Ending balance, shares at Mar. 31, 2021   22,075,638      
Beginning balance, amount at Dec. 31, 2021 (17,286,423) $ 23,524 16,380,597 (33,543,351) (147,193)
Beginning balance, shares at Dec. 31, 2021   23,523,969      
Net income (loss) (13,962)     (13,962)  
Foreign currency translation loss (41,949)       (41,949)
Stock options exercised 195,456 $ 220 195,236    
Stock options exercised, share   219,999      
Share-based compensation 310,002 $ 19 309,983    
Share based compensation, share   18,965      
Ending balance, amount at Mar. 31, 2022 $ (16,836,876) $ 23,763 $ 16,885,816 $ (33,557,313) $ (189,142)
Ending balance, shares at Mar. 31, 2022   23,762,933